SE468973B - Nytt terapeutiskt preparat innehaallande hydrerade ergotalkaloider och heparin - Google Patents

Nytt terapeutiskt preparat innehaallande hydrerade ergotalkaloider och heparin

Info

Publication number
SE468973B
SE468973B SE8306792A SE8306792A SE468973B SE 468973 B SE468973 B SE 468973B SE 8306792 A SE8306792 A SE 8306792A SE 8306792 A SE8306792 A SE 8306792A SE 468973 B SE468973 B SE 468973B
Authority
SE
Sweden
Prior art keywords
molecular weight
component
heparin
composition according
solution
Prior art date
Application number
SE8306792A
Other languages
English (en)
Swedish (sv)
Other versions
SE8306792L (sv
SE8306792D0 (sv
Inventor
H Buehlmann
D Welzel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8306792D0 publication Critical patent/SE8306792D0/xx
Publication of SE8306792L publication Critical patent/SE8306792L/xx
Publication of SE468973B publication Critical patent/SE468973B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8306792A 1982-12-10 1983-12-08 Nytt terapeutiskt preparat innehaallande hydrerade ergotalkaloider och heparin SE468973B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (3)

Publication Number Publication Date
SE8306792D0 SE8306792D0 (sv) 1983-12-08
SE8306792L SE8306792L (sv) 1984-06-11
SE468973B true SE468973B (sv) 1993-04-26

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306792A SE468973B (sv) 1982-12-10 1983-12-08 Nytt terapeutiskt preparat innehaallande hydrerade ergotalkaloider och heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (fr)
AT (1) AT382514B (fr)
AU (1) AU570658B2 (fr)
BE (1) BE898356A (fr)
CA (1) CA1224416A (fr)
CH (1) CH656533A5 (fr)
CY (1) CY1509A (fr)
DD (1) DD215469B3 (fr)
DK (1) DK162475C (fr)
FR (1) FR2537435B1 (fr)
GB (1) GB2131691B (fr)
GR (1) GR79745B (fr)
HK (1) HK23290A (fr)
HU (1) HU190513B (fr)
IE (1) IE56366B1 (fr)
IL (1) IL70406A (fr)
IT (1) IT1172368B (fr)
LU (1) LU85127A1 (fr)
NL (1) NL8304221A (fr)
NZ (1) NZ206523A (fr)
PH (1) PH23451A (fr)
PT (1) PT77803B (fr)
SE (1) SE468973B (fr)
SG (1) SG53989G (fr)
ZA (1) ZA839200B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (fr) * 1988-04-09 1989-10-18 Bioiberica, S.A. Procédé de préparation de fractions oligosaccharides par une dépolymérisation chimique réglée d'héparine
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792L (sv) 1984-06-11
JPS59116222A (ja) 1984-07-05
FR2537435A1 (fr) 1984-06-15
IE832896L (en) 1984-06-10
AU2222183A (en) 1984-06-14
ZA839200B (en) 1985-07-31
AU570658B2 (en) 1988-03-24
DD215469B3 (de) 1988-03-09
GB2131691B (en) 1986-12-03
CA1224416A (fr) 1987-07-21
IL70406A (en) 1988-08-31
HUT34124A (en) 1985-02-28
GB8332653D0 (en) 1984-01-11
BE898356A (fr) 1984-06-04
PT77803A (en) 1984-01-01
IT8349456A0 (it) 1983-12-07
IL70406A0 (en) 1984-03-30
GB2131691A (en) 1984-06-27
DK162475B (da) 1991-11-04
CY1509A (en) 1990-08-03
CH656533A5 (de) 1986-07-15
AT382514B (de) 1987-03-10
HU190513B (en) 1986-09-29
ATA428483A (de) 1986-08-15
SG53989G (en) 1989-12-29
NZ206523A (en) 1987-04-30
PH23451A (en) 1989-08-07
PT77803B (en) 1986-04-17
SE8306792D0 (sv) 1983-12-08
HK23290A (en) 1990-04-06
IT1172368B (it) 1987-06-18
LU85127A1 (fr) 1984-10-22
DK565783D0 (da) 1983-12-08
NL8304221A (nl) 1984-07-02
FR2537435B1 (fr) 1987-03-20
GR79745B (fr) 1984-10-31
JPH0672101B2 (ja) 1994-09-14
DK565783A (da) 1984-06-11
DD215469A5 (de) 1984-11-14
IE56366B1 (en) 1991-07-03
DK162475C (da) 1992-05-11

Similar Documents

Publication Publication Date Title
EP1355674B1 (fr) Inhibiteurs de thrombine a couplage oligo alkylene-glycol ou polyalkylene-glycol
EP0143478B1 (fr) Solution aqueuse acide stable de cis-platinum appropriée à l'injection
EP1956908A2 (fr) Compositions et procedes de traitement
IL307571A (en) A multi-mode convertible vehicle
SE468973B (sv) Nytt terapeutiskt preparat innehaallande hydrerade ergotalkaloider och heparin
DE112016001715T5 (de) Stabile flüssige pharmazeutische Zusammensetzungen von Bortezomib
AU2001260935B2 (en) Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
AU2011254651B2 (en) Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
ES2628306T3 (es) Succinilato de caseína de hierro (III) y procedimiento para la preparación del mismo
EP0206322A2 (fr) N-(2-carboxy)-éthyl-1,8-naphtalène imide et ses sels pour le traitement des rétinopathies et neuropathies diabétiques
CN105535951B (zh) 一种乌司他丁注射液及其制备方法
AU2011254651A1 (en) Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
JP5500162B2 (ja) 点眼剤
WO2017061663A1 (fr) Procédé de préparation de préparation ophtalmique contenant de la thymosine bêta-4
EP0420224A1 (fr) Composition contre les hépatopathies
RU2254852C1 (ru) Раствор для инъекций, обладающий выраженным анальгетическим действием, и способ его получения
CN107744501A (zh) 一种汉防己碱的注射用药物组合物
JP4961671B2 (ja) 点眼剤
KR100671449B1 (ko) 송아지의 제단백 혈액 추출물을 함유하는 점안용 액제조성물
DK155144B (da) Fremgangsmaade til fremstilling af stabile oploesninger af en blanding af hydrogenerede ergotalkaloider og heparin
CA2140813A1 (fr) Flavolignanes servant d'adjuvants dans le traitement des tumeurs
CN107823130A (zh) 一种汉防己碱注射制剂药物组合物的制备方法
EP4353248A1 (fr) Composition d'agoniste du récepteur de détection du calcium et son application
CN104940189A (zh) 治疗增生病的组合物
JP2024108185A (ja) イオン液体、及び医薬組成物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8306792-6

Format of ref document f/p: F